Collegium Pharmaceutical, Inc. (COLL)
34.21
+0.59
(+1.75%)
USD |
NASDAQ |
May 20, 16:00
34.21
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Shareholders Equity (Quarterly) : 312.42M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 54.59M |
| Amneal Pharmaceuticals, Inc. | -45.41M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
| Johnson & Johnson | 81.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.652B |
| Total Liabilities (Quarterly) | 1.340B |
| Debt to Equity Ratio | 2.976 |
| Current Ratio | 1.714 |
| Net Debt Paydown Yield | 0.94% |